Mirikizumab improves fatigue, bowel urgency, and quality of life in patients with moderately to severely active Crohn's Disease: Results from a phase 3 clinical trial

S. Travis, T. Hisamatsu,M. Fischer,M. Dubinsky,V. Jairath,M. Chen,M. Ferrante, L. Peyrin-Biroulet,B. Siegmund, T. Hunter Gibble, Z. Lin,M. Protic,N. Morris,S. Ghosh

JOURNAL OF CROHNS & COLITIS(2024)

引用 0|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要